PHILADELPHIA, Feb. 14, 2018 /PRNewswire/ -- Susan Stein, MPH, CEO and Founder of the award-winning Connexion Healthcare,has announced the open-access publication of rare disease patient advocacy guidelines for interaction with biopharmaceutical companies, the first publication of its kind. Affecting approximately 350 million people, rare diseases are now a global public
About the Guidelines
Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases, can be found at https://ojrd.biomedcentral.com/articles/10.1186/s13023-018-0761-2 or request a copy at email@example.com
About Connexion Healthcare
Connexion Healthcare is an award-winning, full-service thought leader engagement and education agency founded in 1999. Connexion is focused on educating healthcare professionals, advocates, patients and caregivers by providing accurate and clear scientific exchanges, and combining our dedication to scientific excellence with a thorough understanding of business objectives and strategies. Connexion is a certified woman-owned business and member of the Women's Business Enterprise National Council (WBENC), with main offices located in Philadelphia, PA. We invite you to visit our website at connexionhealthcare.com and tweet us @ConnexionHC.
CONTACT: Susan Stein, MPH CEO, Connexion Healthcare Phone: 215.944.9405 Email: firstname.lastname@example.org Twitter: @CONNEXIONhealth
View original content:http://www.prnewswire.com/news-releases/inaugural-rare-disease-patient-advocacy-guidelines-published-300598865.html
SOURCE Connexion Healthcare
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...